Vanda Pharma Insider Flip‑Flop: Owner Sells 30,000 Shares as CEO and Executives Buy Big, Hinting at Personal Portfolio Moves Amid Bullish Sentiment
Vanda Pharmaceuticals insider sale vs. exec buying: 30K shares sold, CEO buys 525K – investors see portfolio shift, not a bearish signal.
3 minutes to read
